Trial intelligence / Profile preview

Albumin versus Ringer's solution for intraoperative plasma volume and hemodynamic optimization during laparoscopic abdominal surgery

2024-513159-33-00Phase 4Completed

Sponsor
Region Östergötland
Start
Sep 2023
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of albumin (human) and ringer's solution (2 arms), sponsored by Region Östergötland. Primary endpoint: Hemoglobin decrease associated with fluid bolus. Started Sep 2023; status: completed.

02

Drugs

albumin (human)ringer's solution

Beyond the preview

Go deeper on 2024-513159-33-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-513159-33-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call